List of Tables
Table 1. Global Patient In-vivo Dosimetry (IVD) System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Patient In-vivo Dosimetry (IVD) System Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Patient In-vivo Dosimetry (IVD) System Market Competitive Situation by Manufacturers in 2024
Table 4. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Patient In-vivo Dosimetry (IVD) System Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Patient In-vivo Dosimetry (IVD) System Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Patient In-vivo Dosimetry (IVD) System Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Patient In-vivo Dosimetry (IVD) System, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Patient In-vivo Dosimetry (IVD) System, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Patient In-vivo Dosimetry (IVD) System, Product Type & Application
Table 12. Global Key Manufacturers of Patient In-vivo Dosimetry (IVD) System, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Patient In-vivo Dosimetry (IVD) System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient In-vivo Dosimetry (IVD) System as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Patient In-vivo Dosimetry (IVD) System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Patient In-vivo Dosimetry (IVD) System Sales by Region (2020-2025) & (K Units)
Table 18. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2020-2025)
Table 19. Global Patient In-vivo Dosimetry (IVD) System Sales by Region (2026-2031) & (K Units)
Table 20. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2026-2031)
Table 21. Global Patient In-vivo Dosimetry (IVD) System Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2020-2025)
Table 23. Global Patient In-vivo Dosimetry (IVD) System Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2026-2031)
Table 25. North America Patient In-vivo Dosimetry (IVD) System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Patient In-vivo Dosimetry (IVD) System Sales by Country (2020-2025) & (K Units)
Table 27. North America Patient In-vivo Dosimetry (IVD) System Sales by Country (2026-2031) & (K Units)
Table 28. North America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2020-2025) & (K Units)
Table 32. Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2026-2031) & (K Units)
Table 33. Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Patient In-vivo Dosimetry (IVD) System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Patient In-vivo Dosimetry (IVD) System Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Patient In-vivo Dosimetry (IVD) System Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) by Type (2020-2025)
Table 51. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) by Type (2026-2031)
Table 52. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2020-2025)
Table 53. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2026-2031)
Table 54. Global Patient In-vivo Dosimetry (IVD) System Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Patient In-vivo Dosimetry (IVD) System Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2020-2025)
Table 57. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2026-2031)
Table 58. Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit) by Type (2020-2025)
Table 59. Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit) by Type (2026-2031)
Table 60. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) by Application (2020-2025)
Table 61. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) by Application (2026-2031)
Table 62. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2020-2025)
Table 63. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2026-2031)
Table 64. Global Patient In-vivo Dosimetry (IVD) System Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Patient In-vivo Dosimetry (IVD) System Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application (2020-2025)
Table 67. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application (2026-2031)
Table 68. Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit) by Application (2020-2025)
Table 69. Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit) by Application (2026-2031)
Table 70. Landauer Company Information
Table 71. Landauer Description and Business Overview
Table 72. Landauer Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Landauer Patient In-vivo Dosimetry (IVD) System Product
Table 74. Landauer Recent Developments/Updates
Table 75. Chiyoda Technol Corporation Company Information
Table 76. Chiyoda Technol Corporation Description and Business Overview
Table 77. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product
Table 79. Chiyoda Technol Corporation Recent Developments/Updates
Table 80. Mirion Technologies Company Information
Table 81. Mirion Technologies Description and Business Overview
Table 82. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product
Table 84. Mirion Technologies Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Fuji Electric Company Information
Table 91. Fuji Electric Description and Business Overview
Table 92. Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Fuji Electric Patient In-vivo Dosimetry (IVD) System Product
Table 94. Fuji Electric Recent Developments/Updates
Table 95. Hitachi Aloka Company Information
Table 96. Hitachi Aloka Description and Business Overview
Table 97. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product
Table 99. Hitachi Aloka Recent Developments/Updates
Table 100. Bertin Instruments Company Information
Table 101. Bertin Instruments Description and Business Overview
Table 102. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product
Table 104. Bertin Instruments Recent Developments/Updates
Table 105. Tracerco Company Information
Table 106. Tracerco Description and Business Overview
Table 107. Tracerco Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Tracerco Patient In-vivo Dosimetry (IVD) System Product
Table 109. Tracerco Recent Developments/Updates
Table 110. ATOMTEX Company Information
Table 111. ATOMTEX Description and Business Overview
Table 112. ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. ATOMTEX Patient In-vivo Dosimetry (IVD) System Product
Table 114. ATOMTEX Recent Developments/Updates
Table 115. Panasonic Company Information
Table 116. Panasonic Description and Business Overview
Table 117. Panasonic Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Panasonic Patient In-vivo Dosimetry (IVD) System Product
Table 119. Panasonic Recent Developments/Updates
Table 120. Polimaster Company Information
Table 121. Polimaster Description and Business Overview
Table 122. Polimaster Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Polimaster Patient In-vivo Dosimetry (IVD) System Product
Table 124. Polimaster Recent Developments/Updates
Table 125. Renri Company Information
Table 126. Renri Description and Business Overview
Table 127. Renri Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Renri Patient In-vivo Dosimetry (IVD) System Product
Table 129. Renri Recent Developments/Updates
Table 130. RadPro International GmbH Company Information
Table 131. RadPro International GmbH Description and Business Overview
Table 132. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product
Table 134. RadPro International GmbH Recent Developments/Updates
Table 135. Ludlum Measurements Company Information
Table 136. Ludlum Measurements Description and Business Overview
Table 137. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product
Table 139. Ludlum Measurements Recent Developments/Updates
Table 140. XZ LAB Company Information
Table 141. XZ LAB Description and Business Overview
Table 142. XZ LAB Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. XZ LAB Patient In-vivo Dosimetry (IVD) System Product
Table 144. XZ LAB Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Patient In-vivo Dosimetry (IVD) System Distributors List
Table 148. Patient In-vivo Dosimetry (IVD) System Customers List
Table 149. Patient In-vivo Dosimetry (IVD) System Market Trends
Table 150. Patient In-vivo Dosimetry (IVD) System Market Drivers
Table 151. Patient In-vivo Dosimetry (IVD) System Market Challenges
Table 152. Patient In-vivo Dosimetry (IVD) System Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Patient In-vivo Dosimetry (IVD) System
Figure 2. Global Patient In-vivo Dosimetry (IVD) System Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Patient In-vivo Dosimetry (IVD) System Market Share by Type: 2024 & 2031
Figure 4. Portable Product Picture
Figure 5. Fixed Product Picture
Figure 6. Global Patient In-vivo Dosimetry (IVD) System Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Patient In-vivo Dosimetry (IVD) System Market Share by Application: 2024 & 2031
Figure 8. Medical
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Global Patient In-vivo Dosimetry (IVD) System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Patient In-vivo Dosimetry (IVD) System Market Size (2020-2031) & (US$ Million)
Figure 13. Global Patient In-vivo Dosimetry (IVD) System Sales (2020-2031) & (K Units)
Figure 14. Global Patient In-vivo Dosimetry (IVD) System Average Price (US$/Unit) & (2020-2031)
Figure 15. Patient In-vivo Dosimetry (IVD) System Report Years Considered
Figure 16. Patient In-vivo Dosimetry (IVD) System Sales Share by Manufacturers in 2024
Figure 17. Global Patient In-vivo Dosimetry (IVD) System Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Patient In-vivo Dosimetry (IVD) System Players: Market Share by Revenue in Patient In-vivo Dosimetry (IVD) System in 2024
Figure 19. Patient In-vivo Dosimetry (IVD) System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Patient In-vivo Dosimetry (IVD) System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2020-2031)
Figure 22. North America Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2020-2031)
Figure 23. United States Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2020-2031)
Figure 26. Europe Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2020-2031)
Figure 27. Germany Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2020-2031)
Figure 34. China Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2020-2031)
Figure 44. Latin America Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Patient In-vivo Dosimetry (IVD) System by Type (2020-2031)
Figure 54. Global Revenue Market Share of Patient In-vivo Dosimetry (IVD) System by Type (2020-2031)
Figure 55. Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Patient In-vivo Dosimetry (IVD) System by Application (2020-2031)
Figure 57. Global Revenue Market Share of Patient In-vivo Dosimetry (IVD) System by Application (2020-2031)
Figure 58. Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit) by Application (2020-2031)
Figure 59. Patient In-vivo Dosimetry (IVD) System Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
